VITROLIFE AB

Vitrolife stock climbs 5.94%, up 16% YTD, with a 200‑day SMA at SEK 97.16 and 52‑week high at SEK 152.5 – learn why investors favor this biotech leader.

Vitrolife shares hover above their 200‑day SMA at SEK 102.70, showing a bullish short‑term bias and solid biotech upside for investors.